Philips partners with DiA Imaging Analysis to enhance ultrasound with AI-based image quantification
March 02 2021 - 8:00AM
Philips partners with DiA Imaging Analysis to enhance ultrasound
with AI-based image quantification
March 2, 2021
Amsterdam, the Netherlands and Be'er Sheva, Israel –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, and DiA Imaging Analysis Ltd., a leading provider of
AI-powered applications for ultrasound, today announced a strategic
partnership* to deliver automated solutions to clinicians at the
point-of-care. Philips’ industry leading ultrasound image quality
combined with DiA’s AI library of automated solutions will help
increase diagnostic confidence, operational efficiency, and access
to care for Point-of-Care customers in and out of the hospital.
Philips continues to build suites of intelligent and automated
enhancements integrated into Radiology workflows across its
portfolio to benefit customers and patients alike. By facilitating
the development and integration of AI-enabled applications, Philips
aims to enhance its ability to deliver on the Quadruple Aim of
better patient outcomes, improved patient and staff experiences and
lower cost of care. The integration of AI applications within
ultrasound technology can also help lead to improved access to
care.
While ultrasound is a cost-efficient diagnostic imaging
modality, it currently requires a significant level of operator
experience and visual interpretation to use it effectively. In
particular, the subjectivity and variability associated with visual
interpretation pose a challenge for longitudinal assessments to
gauge patient improvement or deterioration. To reduce the
variability, improve the efficiency and increase the accuracy of
image analysis, DiA Imaging has developed FDA cleared and CE-marked
AI-enabled 2D ultrasound applications.
“This partnership with DiA Imaging Analysis reinforces Philips’
commitment to integrating AI partners into the Radiology workflow
ecosystem, from the modality, to interpretation, all the way
through to results communication,” said Kees Wesdorp, Chief
Business Leader, Precision Diagnosis at Philips. “Through our
strategic partnership with DiA Imaging Analysis, we can deliver
unprecedented diagnostic confidence and operational efficiency to
point-of-care ultrasound imaging, as well as widen access to high
quality and timely care both inside and outside of
hospitals.”
“With superb image quality and ability to operate with
smartphones and tablets, Philips Ultrasound devices are widely
accepted as the industry’s most advanced solution for point-of-care
imaging. As such, it is the ideal platform for deploying AI-enabled
solutions that will benefit patients by helping clinicians to make
better-informed decisions,” said Hila Goldman Aslan, CEO and
Co-Founder, of DiA Imaging Analysis Ltd.
DiA’s AI technology automates the process of manually capturing
and visually analyzing ultrasound images. The company’s LVivo
Toolbox includes a range of FDA cleared and CE marked automated
AI-enabled apps focused on cardiac and abdominal ultrasound
analysis to help support clinicians with varying levels of
ultrasound experience.
Philips will spotlight its AI-enabled solutions across its
imaging portfolio at the upcoming European Congress of
Radiology 2021 virtual event (March 3-7, 2021). For more
information on Philips’ new portfolio of diagnostic and
interventional solutions, including the new Philips Abdominal
Aortic Aneurysm (AAA) Model which seamlessly integrates 3D
Ultrasound with innovative software in a single solution, visit the
Philips ECR site, and follow @PhilipsLiveFrom for updates
throughout the event.
* As part of the partnership, Philips owns a minority interest
in DiA Imaging Analysis.
For further information, please contact:
Kathy O’ReillyPhilips Global Press OfficeTel.: +1
978-221-8919E-mail : kathy.oreilly@philips.comTwitter:
@kathyoreilly
Edith SchlangerDiA Imaging AnalysisE-mail:
edith@dia-analysis.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being, and enabling better outcomes across the health
continuum – from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2020 sales of EUR 19.5 billion and
employs approximately 82,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
About DiA Imaging Analysis Ltd.
DiA Imaging Analysis is a leading provider of AI-powered
ultrasound analysis solutions that make the use and analysis of
ultrasound images smarter, faster and accessible to all. The
company's FDA cleared and CE marked LVivo product line for cardiac
and abdominal auto analysis allow clinicians with various levels of
ultrasound experience to use and analyze ultrasound images on their
ultrasound devices or healthcare IT systems with increased speed,
efficiency and accuracy. DiA currently serves thousands of end
users worldwide. For additional information, please
visit www.dia-analysis.com
- Philips enhances ultrasound with AI-based image
quantification
- Philips integration of AI applications within Point of Care
Ultrasound
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Sep 2023 to Sep 2024